Literature DB >> 9677343

Sheep mast-cell proteinases-1 and -3: cDNA cloning, primary structure and molecular modelling of the enzymes and further studies on substrate specificity.

S M McAleese1, A D Pemberton, M E McGrath, J F Huntley, H R Miller.   

Abstract

Sheep mast-cell proteinase-1 (sMCP-1) is a serine proteinase expressed predominantly by mucosal mast cells, with specificity for cleavage C-terminal to basic and hydrophobic amino acid residues. A cDNA encoding sMCP-1 has been cloned using reverse transcriptase (RT)-PCR. It appears to be translated as a pre-proenzyme with a 17-amino-acid signal peptide, a basic 2-amino-acid propeptide and a 226-amino-acid catalytic domain. A second cDNA, encoding a serine proteinase 90% identical with sMCP-1, was also cloned and named sMCP-3. Molecular models were constructed for both enzymes using coordinates for the refined X-ray structures of human cathepsin G, chymase and rat mast-cell proteinase-2. The model for sMCP-1 suggests that the acidic Asp-226 side chain extends into the substrate-binding pocket, hydrogen-bonding with Ser-190 on the opposite side and bisecting the pocket. The location of an acidic moiety in this position would favour interaction with basic substrate residues and binding of aromatic residues is rationalized by interaction of the positively charged equatorial plane with Asp-226. The balance between chymotryptic and tryptic activities of sMCP-1 was found to be sensitive to salt concentration, with increasing univalent cation concentration favouring chymotryptic activity relative to the tryptic. Using a peptide substrate representing residues 36-59 of the human thrombin receptor, increasing salt concentration favoured cleavage at Phe-43 rather than at Arg-41.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677343      PMCID: PMC1219647          DOI: 10.1042/bj3330801

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  The isolation and purification of a dual specific mast cell-derived protease from parasitised caprine jejunal tissue.

Authors:  C N Macaldowie; A Mackellar; J F Huntley
Journal:  Res Vet Sci       Date:  1998 Jan-Feb       Impact factor: 2.534

2.  Subcellular localization, substrate specificity and crystallization of duodenase, a potential activator of enteropeptidase.

Authors:  T S Zamolodchikova; E A Sokolova; S L Alexandrov; I I Mikhaleva; I A Prudchenko; I A Morozov; N V Kononenko; O A Mirgorodskaya; U Da; N I Larionova; V F Pozdnev; D Ghosh; W L Duax; T I Vorotyntseva
Journal:  Eur J Biochem       Date:  1997-10-15

3.  Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes.

Authors:  J Schmid; C Weissmann
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

4.  Cloning of the mast cell protease, RMCP II. Evidence for cell-specific expression and a multi-gene family.

Authors:  P N Benfey; F H Yin; P Leder
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

5.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

6.  The effects of recombinant ovine interleukin-3 and recombinant ovine stem cell factor on the growth and mediator expression of caprine and ovine bone marrow-derived mast cells.

Authors:  C N Macaldowie; J F Huntley; A Mackellar; C McInnes; D M Haig
Journal:  Vet Immunol Immunopathol       Date:  1997-12-12       Impact factor: 2.046

7.  Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors.

Authors:  J C Powers; T Tanaka; J W Harper; Y Minematsu; L Barker; D Lincoln; K V Crumley; J E Fraki; N M Schechter; G G Lazarus
Journal:  Biochemistry       Date:  1985-04-09       Impact factor: 3.162

Review 8.  Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis.

Authors:  A Janoff
Journal:  Am Rev Respir Dis       Date:  1985-08

9.  Human leukocyte cathepsin G. Subsite mapping with 4-nitroanilides, chemical modification, and effect of possible cofactors.

Authors:  T Tanaka; Y Minematsu; C F Reilly; J Travis; J C Powers
Journal:  Biochemistry       Date:  1985-04-09       Impact factor: 3.162

10.  Location of disulphide bridges by diagonal paper electrophoresis. The disulphide bridges of bovine chymotrypsinogen A.

Authors:  J R Brown; B S Hartley
Journal:  Biochem J       Date:  1966-10       Impact factor: 3.857

View more
  5 in total

1.  Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution.

Authors:  Maike Gallwitz; Jenny M Reimer; Lars Hellman
Journal:  Immunogenetics       Date:  2006-06-29       Impact factor: 2.846

Review 2.  Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut.

Authors:  Hugh R P Miller; Alan D Pemberton
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

3.  Cloning and sequencing of the equine and ovine high-affinity IgE receptor beta-and gamma-chain cDNA.

Authors:  S M McAleese; H R P Miller
Journal:  Immunogenetics       Date:  2003-04-23       Impact factor: 2.846

4.  Novel gene expression responses in the ovine abomasal mucosa to infection with the gastric nematode Teladorsagia circumcincta.

Authors:  Pamela A Knight; Susan E Griffith; Alan D Pemberton; Judith M Pate; Lauren Guarneri; Katherine Anderson; Richard T Talbot; Sarah Smith; David Waddington; Mark Fell; Alan L Archibald; Stewart T G Burgess; David W Smith; Hugh R P Miller; Ivan W Morrison
Journal:  Vet Res       Date:  2011-06-17       Impact factor: 3.683

5.  Identification and annotation of bovine granzyme genes reveals a novel granzyme encoded within the trypsin-like locus.

Authors:  Jie Yang; Christina Vrettou; Tim Connelley; W Ivan Morrison
Journal:  Immunogenetics       Date:  2018-06-08       Impact factor: 2.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.